CARDIFF-BY-THE-SEA, Calif., Sept. 18, 2023 /PRNewswire/ — Field Medical, Inc. (Field Medical), an emerging leader in cardiac catheter ablation, announced today that it has closed its oversubscribed seed round with investments totaling $14M. The convertible note funding was led by private investors who […]
Financial
JenaValve Appoints Shlomi Nachman to Board of Directors
IRVINE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that it has appointed Shlomi Nachman, experienced cardiovascular industry executive, to its Board of Directors. Mr. Nachman […]
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will […]
Protaryx Medical Welcomes David Mester as New CEO to Spearhead Advancements in Transseptal Access Technology
BALTIMORE–(BUSINESS WIRE)–Protaryx Medical, a pioneer in medical device innovation, today announced the appointment of David Mester, MBA as its new chief executive officer (CEO). With a career spanning over 33 years in the structural heart medical device industry, Mester brings […]
Shockwave Medical Appoints Nick West as Associate Chief Medical Officer
SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, […]
Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024
SANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Chief Financial Officer Dan Puckett plans to […]
LIB Therapeutics Appoints David Cory as Chief Executive Officer as Lead Clinical Programs Achieve Phase 3 Completion
CINCINNATI–(BUSINESS WIRE)–LIB Therapeutics Inc. (LIB), a late-stage biopharmaceutical company developing subcutaneous and oral PCSK9 inhibitor therapies for patients at very high and high-risk of cardiovascular disease (CVD), today announced that the Board of Directors has appointed David Cory as Chief […]
Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a New Technology Add-on Payment for the DETOUR System
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the U. S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on […]
VeinWay Closes Oversubscribed SAFE Round and Begins Series A Round
Vascular Surgeons Stephen Black, MD, and Houman Jalaie, MD, PhD join VeinWay’s Scientific Advisory Board. OR YEHUDA, Israel, Sept. 7, 2023 /PRNewswire/ — VeinWay has closed an oversubscribed SAFE round of investment and has opened a series A round. The funds will be used […]
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
PARIS–(BUSINESS WIRE)– Gradient Denervation Technologies (“Gradient”), a medical device company developing an innovative catheter-based solution for the treatment of pulmonary hypertension, announces today the successful closing of a €14m Series A financing that will support ongoing clinical development and evaluation of the […]